CBIO
CRESCENT BIOPHARMA, INC.Company with tickers: CBIO
CIK
1253689
CUSIP
G2545C104
Shares Outstanding
27,571,935
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-12-15 | Lynch Ryan | See Remarks | Award | 33,512 |
| 2025-12-15 | Lynch Ryan | See Remarks | Award | 4,000 |
| 2025-12-15 | Lynch Ryan | See Remarks | Award | 8,378 |
| 2025-12-15 | Bispham Barbara Harlin | See Remarks | Award | 72,185 |
| 2025-12-15 | Bispham Barbara Harlin | See Remarks | Award | 6,000 |
| 2025-12-15 | Bispham Barbara Harlin | See Remarks | Award | 12,422 |
| 2025-12-15 | Pinkas Jan | Chief Scientific Officer | Award | 17,507 |
| 2025-12-15 | Pinkas Jan | Chief Scientific Officer | Award | 5,000 |
| 2025-12-15 | Pinkas Jan | Chief Scientific Officer | Award | 70,025 |
| 2025-12-15 | Doughty Christopher Grant | Chief Business Officer | Award | 58,855 |
| 2025-12-15 | Doughty Christopher Grant | Chief Business Officer | Award | 14,714 |
| 2025-12-15 | Doughty Christopher Grant | Chief Business Officer | Award | 8,000 |
| 2025-12-15 | Brumm Joshua T | Director, Chief Executive Officer | Award | 10,000 |
| 2025-12-15 | Brumm Joshua T | Director, Chief Executive Officer | Award | 180,467 |
| 2025-12-15 | Brumm Joshua T | Director, Chief Executive Officer | Award | 45,117 |
| 2025-12-15 | Scalzo Richard William | Chief Financial Officer | Award | 5,000 |
| 2025-12-15 | Scalzo Richard William | Chief Financial Officer | Award | 14,422 |
| 2025-12-15 | Scalzo Richard William | Chief Financial Officer | Award | 57,688 |
| 2025-12-15 | McNeill Jonathan | President and COO | Award | 78,029 |
| 2025-12-15 | McNeill Jonathan | President and COO | Award | 6,000 |
| 2025-12-15 | McNeill Jonathan | President and COO | Award | 19,507 |
| 2025-12-15 | Im Ellie Eunkyung | Chief Medical Officer | Award | 65,190 |
| 2025-12-15 | Im Ellie Eunkyung | Chief Medical Officer | Award | 5,000 |
| 2025-12-15 | Im Ellie Eunkyung | Chief Medical Officer | Award | 16,298 |
| 2025-12-08 | McNeill Jonathan | President and COO | Award | 172,836 |
| 2025-12-08 | Brumm Joshua T | Director, Chief Executive Officer | Award | 345,672 |
| 2025-12-04 | Fairmount Funds Management LLC | Director | Buy | 1,360,000 |
| 2025-12-04 | Fairmount Funds Management LLC | Director | Buy | 131,434 |
| 2025-07-16 | Pinkas Jan | Chief Scientific Officer | Award | 142,474 |
| 2025-07-07 | Pinkas Jan | Chief Scientific Officer | Other | 0 |
| 2025-06-23 | Violin Jonathan | Director | Award | 9,023 |
| 2025-06-23 | Balcom Alexandra | Chief Financial Officer | Award | 9,023 |
| 2025-06-23 | Moran Susan | Director | Award | 9,023 |
| 2025-06-23 | Fairmount Funds Management LLC | Director | Award | 9,023 |
| 2025-06-23 | Lubner David Charles | Director | Award | 9,023 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 304,098 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 25,944 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 257,515 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 657,308 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 56,079 |
| 2025-06-13 | BVF PARTNERS L P/IL | 10% Owner | Other | 556,617 |
| 2025-06-13 | Im Ellie Eunkyung | Chief Medical Officer | Other | 0 |
| 2025-06-13 | Bispham Barbara Harlin | See Remarks | Other | 0 |
| 2025-06-13 | Doughty Christopher Grant | Chief Business Officer | Other | 39,480 |
| 2025-06-13 | Doughty Christopher Grant | Chief Business Officer | Other | 0 |
| 2025-06-13 | McNeill Jonathan | President and COO | Other | 134,200 |
| 2025-06-13 | McNeill Jonathan | President and COO | Other | 0 |
| 2025-06-13 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2025-06-13 | Fairmount Funds Management LLC | Director | Other | 1,387,866 |
| 2025-06-13 | Fairmount Funds Management LLC | Director | Other | 0 |
| 2025-06-13 | Violin Jonathan | Director | Other | 69,515 |
| 2025-06-13 | Violin Jonathan | Director | Other | 0 |
| 2025-06-13 | Moran Susan | Director | Other | 0 |
| 2025-06-13 | Lynch Ryan | See Remarks | Other | 0 |
| 2025-06-13 | Scalzo Richard William | Chief Financial Officer | Other | 0 |
| 2025-06-13 | Brumm Joshua T | Director, Chief Executive Officer | Other | 268,400 |
| 2025-06-13 | Brumm Joshua T | Director, Chief Executive Officer | Other | 0 |
| 2025-06-13 | Lubner David Charles | Director | Other | 0 |
| 2025-06-13 | Balcom Alexandra | Chief Financial Officer | Other | 0 |
| 2024-08-08 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 260,873 |
| 2024-08-07 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 61,488 |
| 2024-08-06 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 55,732 |
| 2024-08-05 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 164,523 |
| 2024-08-02 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 286,200 |
| 2024-08-01 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 63,564 |
| 2024-07-30 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 756,835 |
| 2024-07-29 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 363,949 |
| 2024-07-26 | Invus Public Equities, L.P. | Director, 10% Owner | Sell | 258,335 |
| 2024-07-25 | Siren, L.L.C. | Director, 10% Owner | Other | 8,589,064 |
| 2024-06-21 | Rock Edwin | Chief Medical Officer | Buy | 115,000 |
| 2024-06-20 | Rock Edwin | Chief Medical Officer | Buy | 190,000 |
| 2024-06-18 | Hahn Brian M. | SVP Finance, CFO | Buy | 17,500 |
| 2024-05-01 | Jackson Scott Thomas | Director | Award | 40,000 |
| 2024-05-01 | JUNIUS DANIEL M | Director | Award | 40,000 |
| 2024-05-01 | Goldberg Mark Alan | Director | Award | 40,000 |
| 2024-05-01 | PEARSON TIMOTHY R | Director | Award | 40,000 |
| 2024-05-01 | King Rachel K. | Director | Award | 40,000 |
| 2024-05-01 | Koenig Scott | Director | Award | 40,000 |
| 2024-05-01 | Andrews Patricia S | Director | Award | 40,000 |
| 2024-03-29 | JUNIUS DANIEL M | Director | Award | 5,209 |
| 2024-03-29 | King Rachel K. | Director | Award | 3,334 |
| 2024-03-29 | Goldberg Mark Alan | Director | Award | 4,584 |
| 2024-03-29 | Goldberg Mark Alan | Director | Other | 11,497 |
| 2024-01-12 | Semerjian Harout | Director, Chief Executive Officer | Award | 695,000 |
| 2024-01-12 | Johnson Bruce S | SVP & Chief Commercial Officer | Award | 250,000 |
| 2024-01-12 | Rock Edwin | Chief Medical Officer | Award | 250,000 |
| 2024-01-12 | Rath Chinmaya | SVP and Chief Business Officer | Award | 250,000 |
| 2024-01-12 | Hahn Brian M. | SVP Finance, CFO | Award | 250,000 |
| 2023-12-29 | Andrews Patricia S | Director | Award | 5,191 |
| 2023-12-29 | King Rachel K. | Director | Award | 4,238 |
| 2023-12-29 | King Rachel K. | Director | Other | 92,401 |
| 2023-12-29 | King Rachel K. | Director | Other | 45,741 |
| 2023-12-29 | King Rachel K. | Director | Other | 7,500 |
| 2023-12-29 | Goldberg Mark Alan | Director | Award | 5,827 |
| 2023-12-29 | Goldberg Mark Alan | Director | Other | 11,497 |
| 2023-09-30 | King Rachel K. | Director | Other | 92,401 |
| 2023-09-30 | King Rachel K. | Director | Other | 7,500 |
| 2023-09-30 | King Rachel K. | Director | Award | 6,667 |
| 2023-09-30 | King Rachel K. | Director | Other | 45,741 |
| 2023-09-30 | Andrews Patricia S | Director | Award | 8,167 |